Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$13.12 - $15.03 $388,076 - $444,572
-29,579 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $182,898 - $207,347
-13,508 Reduced 31.35%
29,579 $424,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $24,101 - $30,011
1,830 Added 4.44%
43,087 $478,000
Q3 2021

Nov 15, 2021

SELL
$16.3 - $17.26 $213,464 - $226,036
-13,096 Reduced 24.09%
41,257 $585,000
Q2 2021

Aug 16, 2021

SELL
$16.55 - $18.64 $127,832 - $143,975
-7,724 Reduced 12.44%
54,353 $915,000
Q1 2021

May 17, 2021

SELL
$16.71 - $19.9 $31,715 - $37,770
-1,898 Reduced 2.97%
62,077 $1.13 Million
Q4 2020

Feb 12, 2021

BUY
$15.39 - $18.97 $114,209 - $140,776
7,421 Added 13.12%
63,975 $1.17 Million
Q3 2020

Nov 13, 2020

BUY
$17.1 - $19.19 $50,445 - $56,610
2,950 Added 5.5%
56,554 $1.01 Million
Q2 2020

Nov 20, 2020

SELL
$14.59 - $19.5 $3,326 - $4,446
-228 Reduced 0.42%
53,604 $961,000
Q2 2020

Aug 13, 2020

BUY
$14.59 - $19.5 $11,920 - $15,931
817 Added 1.54%
53,832 $965,000
Q1 2020

May 14, 2020

BUY
$13.02 - $20.31 $1,158 - $1,807
89 Added 0.17%
53,015 $811,000
Q4 2019

Feb 11, 2020

BUY
$16.88 - $20.83 $77,664 - $95,838
4,601 Added 9.52%
52,926 $1.04 Million
Q3 2019

Nov 14, 2019

BUY
$16.15 - $17.99 $19,880 - $22,145
1,231 Added 2.61%
48,325 $831,000
Q2 2019

Nov 21, 2019

BUY
$16.58 - $20.49 $34,420 - $42,537
2,076 Added 4.61%
47,094 $834,000
Q2 2019

Aug 16, 2019

SELL
$16.58 - $20.49 $204,282 - $252,457
-12,321 Reduced 21.49%
45,018 $797,000
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $957,561 - $1.23 Million
57,339 New
57,339 $1.17 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.